Literature DB >> 11005508

Escape mechanisms in tumor immunity: a year 2000 update.

G Pawelec1, S Heinzel, R Kiessling, L Müller, Q Ouyang, J Zeuthen.   

Abstract

The current consensus of opinion has it that most or possibly all tumors, spontaneous as well as induced, are immunogenic, expressing antigens in a form recognizable by the host immune system. Accordingly, in order to progress, tumors have to evolve strategies for evading immune responses. The purpose of this review is to consider the current status of knowledge concerning these different tumor escape strategies. It represents an update of an article originally published in this journal in 1997 (Pawelec, Zeuthen, and Kiessling, 1997). Therefore, it focuses mostly on publications that have appeared since then, illustrating the impressive accumulation of new data since that time and the importance currently attributed to studies of tumor escape from the immune response.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11005508

Source DB:  PubMed          Journal:  Crit Rev Oncog        ISSN: 0893-9675


  5 in total

1.  Blockade of the granzyme B/perforin pathway through overexpression of the serine protease inhibitor PI-9/SPI-6 constitutes a mechanism for immune escape by tumors.

Authors:  J P Medema; J de Jong; L T Peltenburg; E M Verdegaal; A Gorter; S A Bres; K L Franken; M Hahne; J P Albar; C J Melief; R Offringa
Journal:  Proc Natl Acad Sci U S A       Date:  2001-09-18       Impact factor: 11.205

Review 2.  Assumptions of the tumor 'escape' hypothesis.

Authors:  Nicholas P Restifo; Paul A Antony; Steven E Finkelstein; Wolfgang W Leitner; Deborah P Surman; Marc R Theoret; Christopher E Touloukian
Journal:  Semin Cancer Biol       Date:  2002-02       Impact factor: 15.707

3.  CD28 expression in sentinel node biopsies from breast cancer patients in comparison with CD3-zeta chain expression.

Authors:  Jana M Schüle; Leif Bergkvist; Leif Håkansson; Bertil Gustafsson; Annika Håkansson
Journal:  J Transl Med       Date:  2004-12-21       Impact factor: 5.531

4.  In vivo and in vitro antitumor effects of platycodin d, a saponin purified from platycodi radix on the h520 lung cancer cell.

Authors:  Jae Chan Park; Young Joon Lee; Hae Yun Choi; Yong Kook Shin; Jong Dae Kim; Sae Kwang Ku
Journal:  Evid Based Complement Alternat Med       Date:  2014-11-13       Impact factor: 2.629

Review 5.  Cancer treatment: the combination of vaccination with other therapies.

Authors:  Mads Hald Andersen; Rikke Baek Sørensen; David Schrama; Inge Marie Svane; Jürgen C Becker; Per Thor Straten
Journal:  Cancer Immunol Immunother       Date:  2008-02-20       Impact factor: 6.968

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.